title: Paclitaxel plus bevacizumab for metastatic breast cancer.
authors.forename: Antonio
authors.initials: A
authors.lastname: Rossi
authors.forename: Valter
authors.initials: V
authors.lastname: Torri
authors.forename: Cesare
authors.initials: C
authors.lastname: Gridelli
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D015982:Bias; D001943:Breast Neoplasms / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012107:Research Design
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017239:Paclitaxel